Aurobindo Pharma’s Subsidiary CuraTeQ Secures UK Approval for Bevacizumab Biosimilar

SCG Cell Therapy Partners with A*STAR BTI and NATi to Advance RNA-Based Therapeutics

Korea's National Bio Big Data Project: Advancing Precision Medicine with Macrogen and Illumina

GST Exemption Announced for Cancer Treatment Gene Therapy

AIIMS Develops Affordable CAR-T Cell Therapy for Multiple Myeloma

Sangamo Therapeutics and Astellas Collaborate on Innovative Gene Therapy for Neurological Diseases

FDA Clears IND for Arbor Biotechnologies’ ABO-101 Gene Editing Therapeutic for Primary Hyperoxaluria Type 1

Fortis Healthcare Acquires Stake in Agilus Diagnostics

FDA Approves BRAFTOVI® Combination Regimen as First-Line Treatment for BRAF V600E-Mutant Metastatic Colorectal Cancer

The Role of Big Data in Precision Medicine

Caris Life Sciences Celebrates 1,000+ Precision Medicine Studies, Advancing Cancer Research and Patient Outcomes

OncoHelix and Qualisure Diagnostics Partner to Bring Thyroid GuidePx® Test to Canadian Patients

Gates Foundation Invests $50 Million in Tessera Therapeutics to Advance Gene Therapy for Sickle Cell Disease

FDA Approves Ensartinib (Ensacove) as First-Line Treatment for ALK-Positive NSCLC

Guardant Health and Boehringer Ingelheim Collaborate to Advance Liquid Biopsy CDx for HER2-Targeted Therapy in NSCLC

Home
/
update
/
details

Silicon Valley Tech Veteran and Former Illumina CEO Francis deSouza Joins 4baseCare’s Advisory Board

NextEdge Admin

31 Jul 2024

1 min 33 sec

4baseCare, an Illumina Accelerator Company offering cutting-edge precision oncology solutions using advanced genomics and digital health technology, has appointed Francis deSouza to its advisory board. DeSouza, renowned for his leadership as the CEO of Illumina, played a crucial role in making genomics more accessible worldwide by significantly reducing sequencing costs and introducing innovative clinical solutions. During his tenure from 2016 to 2023, Illumina expanded its operations to over 150 countries. “I am excited to join 4baseCare and work with Hitesh and Kshitij. The company’s mission to make genomics accessible and affordable for under-represented populations deeply resonates with me,” deSouza stated. Hitesh Goswami, CEO and Co-Founder of 4baseCare, commented, “Francis deSouza’s extensive experience in growing Illumina aligns with our plan to expand our genomics capabilities in SE Asia and the Middle East. We look forward to working with him to achieve our vision of making genomics accessible and positively impacting millions of cancer patients in the region.”